May 4, 2026 - 18:26

Cybersecurity firm SunStone Information Defense Inc. has filed a lawsuit against Akamai Technologies Inc., accusing the cloud services giant of infringing on its patented cybersecurity technology. The complaint, submitted in a federal court, centers on Akamai's account protector product, which SunStone claims unlawfully uses its proprietary methods for detecting and blocking cyber threats.
According to the legal filing, SunStone holds multiple patents related to advanced threat detection and identity verification systems. The company argues that Akamai's account protector, a service designed to secure user logins and prevent account takeovers, directly copies these innovations without authorization. SunStone is seeking unspecified damages and an injunction to stop Akamai from using the disputed technology.
Akamai, known for its content delivery network and cloud security solutions, has not yet issued a public response to the allegations. The case highlights the growing tension in the cybersecurity industry, where companies often clash over intellectual property as they race to develop new defenses against evolving online threats. Legal experts expect a prolonged battle, as both sides have significant resources and a stake in protecting their market positions. The outcome could set a precedent for how similar patent disputes are handled in the rapidly expanding field of digital security.
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...
September 27, 2026 - 08:32
New Biochip Enables Real-Time Tracking of Parkinson's Treatment ResponseResearchers have created a biochip technology that allows for real-time monitoring of how Parkinson`s disease patients respond to treatment. The development comes from a team working on advanced...